Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Dalhousie University

$23,920.00

Investigating brain penetrance after oral administration of novel cannabinoid extracts in mice

FY 2019-20

Summary
Tidal Health is a licensed medical cannabis producer based in New Brunswick. They are currently developing new cannabinoid extracts but do not have the capability to assess the extent to which these extracts can enter into and affect the brain following oral administration; this needs to be performed in a pre-clinical animal model. Thus, Tidal Health must rely on a collaboration with a basic researcher that uses pre-clinical animal models in order to assess the usability of their extracts. The Franklin laboratory at Dalhousie University focuses on mouse models of neurological disease, and are able to measure cannabinoids in the mouse brain. The proposed collaboration between Tidal Health and the Franklin laboratory aims to quantify the amount of cannabinoids in the brain of young mice administered one of three newly developed extracts (a high cannabidiol (CBD):low delta9-tetrahydrocannbinol (THC), high THC:low CBD, or a balanced mixture of THC:CBD) in order to establish the brain penetrance of active ingredients in these cannabis products. This pre-clinical research is critical for Tidal Health's research and development goals in the field of medical cannabis, which are ultimately focused on creating consistent and effective products for specified health conditions. This work will also provide trainees in the Franklin laboratory important experience in applied neuroscience research, as well as the opportunity to establish relationships with a growing Canadian company.
Program
Engage Grants Program
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
538283-2019
Name nom
Franklin, Tamara
Department département
Psychology and Neuroscience
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
23920
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Investigating brain penetrance after oral administration of novel cannabinoid extracts in mice
Keyword
NSERC
Application summary
Tidal Health is a licensed medical cannabis producer based in New Brunswick. They are currently developing new cannabinoid extracts but do not have the capability to assess the extent to which these extracts can enter into and affect the brain following oral administration; this needs to be performed in a pre-clinical animal model. Thus, Tidal Health must rely on a collaboration with a basic researcher that uses pre-clinical animal models in order to assess the usability of their extracts. The Franklin laboratory at Dalhousie University focuses on mouse models of neurological disease, and are able to measure cannabinoids in the mouse brain. The proposed collaboration between Tidal Health and the Franklin laboratory aims to quantify the amount of cannabinoids in the brain of young mice administered one of three newly developed extracts (a high cannabidiol (CBD):low delta9-tetrahydrocannbinol (THC), high THC:low CBD, or a balanced mixture of THC:CBD) in order to establish the brain penetrance of active ingredients in these cannabis products. This pre-clinical research is critical for Tidal Health's research and development goals in the field of medical cannabis, which are ultimately focused on creating consistent and effective products for specified health conditions. This work will also provide trainees in the Franklin laboratory important experience in applied neuroscience research, as well as the opportunity to establish relationships with a growing Canadian company.